Post navigation Chutes & Ladders—Sarepta CEO to step down as DM1 hits close to homeArna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform